Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$3 Billion potential for Prolanta.
another required filing...
as of the filing, no "definitive" deal in place to merge companies.
we wait...
$5 Million Series B funding raised to date!!
yep...
looks like we're getting close.
the point i'm making is that it appears oncolix has raised upwards of a million dollars or more since what was reported in october.
so in fact, the VC money does not have appeared to have dried up.
it looks to me like they're well on their way to getting funded for a phase II trial.
the real reason they're going public is likely that prolanta has blockbuster potential. it's shown great results in the lab on all kinds of cancers, but to get going they had to take the smaller, less expensive route with ovarian cancer. to get a breast cancer trail, they'd need hundreds of participants. for now it looks like the plan is to get into phase II as soon as they can and find a major biotech buy them out or to have them fund further progress of the ovarian trial and/or other trials.
oncolix is surely aiming for nasdaq to help facilitate these partnerships as much as anything else. the science drives the funding. if the money is coming in, you know the results are good. it appears to me that the money is still coming in.
yes, those are all on file with the SEC.
Jan 2017 -Redman has raised $14M
https://www.b2match.eu/ucis2017/participants/24
his most recent 8k bio says over $15M raised.
hard to say what exactly, but it certainly does look like the VC money is still rolling in.
$1.8M series B raised since Oct.
According to this http://pitchbook.com/profiles/oncolix-profile-investors-funding-valuation-and-analysis
I haven't found anything indicating more than a few hundred thousand sold this round anywhere, so this information is certainly interesting...
excellent.
up to date contact info both there and on otc markets. i'm guessing they're more ready to talk now.
they could easily announce they've sold out their latest funding block at any time. They have that Chinese conference coming up and who knows what else.
Wonder what announcing a $5 million capital raise would do to this stock's value?...
This is all before Phase II trials. If and when they get that far, the potential value of Prolanta really jumps, by the progress with the science if nothing else. They've reported that the capital they're looking to raise now is for Phase II trials which should be a pretty good indication that the current human trials are progressing well. (redman has said as much as well)
All of these past Kistler "failures" you mention, I wonder if they're not because they were crappy companies in the first place that led to failure as much as anything. LaunchTV? I mean come on...Sounds like the exact same typical pink sheet bs as always.
What some of us here think might be different about this deal is that Oncolix, we believe, is a million miles from the typical Launchtv type bs you'd normally see here.
Kister does have a specialized skill set that makes sense to utilize. If not Kistler, then somebody. Navigating through a reverse merger and all of the SEC compliance involved, it's got to be very complicated. I'd rather have Oncolix have somebody looking over their shoulder than not, risking some of these classic beginner paperwork type errors that can throw everything off.
There are certainly plenty of legitimate concerns, but there is also the thought that Oncolix might really be a unique company. We shall see...
As much as we worry about Kistler diluting the shareholder's value, I like to look at the current price and then consider all of the research I've done into Oncolix and I'm quite certain they're worth a good deal more than $4 or $5 million. Can they pull it off? That's a good question, but this management team does have a track record of success in this industry.
Oncolix says Prolanta has the potential to make a $billion per year.
multi multi dollars?
www.oncolixbio.com is no longer active (for the moment). looks like they're working on that website now...the dev site is also down.
also of note, the mailing address has been changed on the OTC page finally from Kistler's address to the Oncolix address in Houston.
on a side note, i take it as good news that no news was released going into this holiday weekend. things are moving...
Inventor of Prolanta also invented Somavert sold by Pfizer. Somavert yielded $232 million in revenues last year.
i think there's too much focus on what will or would be likely be a nominal reverse split at most.
the potential of oncolix should be getting more thought, imo.
keep in mind in biotechs, the drug wouldn't even have to be approved, let alone on the market to start getting that market cap up really high. it's crazy, but the future valuations can get nuts.
With current share structure...
If trials really do finish at the end of the year and are positive.
Then they can launch phase II and get backing from GSK or something else big, the market will start to see that Prolanta is getting closer to getting some of that multi billion dollar female cancer pie.
At a potential of over a billion dollars in sales, does the current $4-$5 million dollar market value seem like a good value to the current investor? hmm
these guys are slick...
not only did they find some promising science and started running with it, but they're also targeting cancers with their trials that have huge markets.
often we'll see these drug companies pick out an obscure cancer or other malady that affects a very small percentage of the population. as they progress through trials, the potential market they'd tap into wouldn't ever be that large, limiting the revenue potential at least until trials can be expanded...long delays and lots of money.
Oncolix has not only achieved orphan drug designation, but they're involved with human trials in a market with an enormous pie. This is exactly how Prolanta could make Oncolix worth a fortune. They'll have to continue progressing with the science of course, but if it is promising they're almost guaranteed to pick up a licensing partner based on past statements and actions from the company.
The price today looks pretty damn cheap to me...
$1 billion per year
how was the "seller" ever going to effectuate a reverse split and a name change after closing?
my guess is that kistler is still a consultant (which he does still seem to be), and is being tasked with 1. releasing the annual report 2. reverse/split and name change.
what are you talking about?
kistler sold 61M shares to redman. that's what's in the form.
the stock dropped becuase it's a thinly traded stock and when one group saw the words reverse split and dumped a million, the panic ensued.
he responds to email. but i don't think he's going to tell you what his intentions are before they're made public.
but for other matters, yes he'll respond to you as he's done with me in recent days.
where do you live?
is this a demand or do you know something?
i'm leaning toward believing this will happen, but i'm not as worried about the consequences as some. the ratio just couldn't be too large or else the stock would never be able to get traded.
with that said, if they do go this route, redman had better be ready to deliver the public a bunch of good news along the way.
it's worth repeating that reverse splits don't *have* to be a terrible thing. if there ever was a set up where it might not be, this would have to be it. no debt, potentially huge valuation in their product, experienced management team, etc., not to mention the price has already tanked as a result of the potential r/s. most importantly, the market cap is probably way too low, but we'll have to see what oncolix has to say about that.
but the company is already down over 100% on the news of the potential R/S.
at $3.5M, how much farther can the value drop? i guess we'll see.
fear of R/S makes sense, but in this case it's probably self-fulfilling.
the market cap here is absurdly low for what we think oncolix is. reasonable R/S or not, many here are ultimately betting on the value coming in line over time.
also says the seller shall change the name of the company.
LOL!!!
that's what AEPP is.
Oncolix just bought AEPP.
Oncolix has stated publicly their intention to go public.
Oncolix has stated publicly their intention to rename AEPP.
Oncolix is a multi-million dollar VC backed private company.
the website is still in development. we're not really supposed to know it's there.
2017
Oncolix, Inc. Announces Acquisition of Public Entity
HOUSTON, TX, April 6, 2017 / -- ONCOLIX, INC., announced today it has finalized the purchase of a public entity (Advanced Engineering and Petroleum Producers, Inc. ("AEPP"). This public vehicle is now a wholly-owned company of Oncolix, Inc. Currently a private Delaware C Corporation, Oncolix is evaluating options that will allow itself to become listed on a public stock exchange.
this management team has been in place for less than a week.
this is a bizarre stance given how much has happened here in the last month.
that and the two in charge have loads of experience in the industry.
wrong
8-k was required. what's your complaint now?